BSX icon

Boston Scientific

106.11 USD
-0.03
0.03%
At close Feb 14, 4:00 PM EST
After hours
106.19
+0.08
0.08%
1 day
-0.03%
5 days
0.37%
1 month
10.94%
3 months
21.14%
6 months
38.85%
Year to date
18.72%
1 year
60.89%
5 years
150.79%
10 years
615.03%
 

About: Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Employees: 48,000

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 13 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

116% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 76

18% more repeat investments, than reductions

Existing positions increased: 552 | Existing positions reduced: 466

6% more funds holding

Funds holding: 1,290 [Q2] → 1,365 (+75) [Q3]

6% more capital invested

Capital invested by funds: $106B [Q2] → $111B (+$5.85B) [Q3]

3% less funds holding in top 10

Funds holding in top 10: 36 [Q2] → 35 (-1) [Q3]

3.06% less ownership

Funds ownership: 93.26% [Q2] → 90.19% (-3.06%) [Q3]

31% less call options, than puts

Call options by funds: $674M | Put options by funds: $972M

Research analyst outlook

13 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$101
5%
downside
Avg. target
$116
10%
upside
High target
$130
23%
upside

13 analyst ratings

13 positive
100%
neutral
0%
negative
0%
Stifel
Rick Wise
65% 1-year accuracy
22 / 34 met price target
13%upside
$120
Buy
Maintained
10 Feb 2025
Barclays
Matt Miksic
82% 1-year accuracy
31 / 38 met price target
11%upside
$118
Overweight
Maintained
10 Feb 2025
UBS
Danielle Antalffy
69% 1-year accuracy
9 / 13 met price target
23%upside
$130
Buy
Maintained
7 Feb 2025
Raymond James
Jayson Bedford
75% 1-year accuracy
18 / 24 met price target
15%upside
$122
Strong Buy
Maintained
6 Feb 2025
RBC Capital
Shagun Singh
61% 1-year accuracy
41 / 67 met price target
9%upside
$116
Outperform
Maintained
6 Feb 2025

Financial journalist opinion

Based on 26 articles about BSX published over the past 30 days

Positive
Zacks Investment Research
4 days ago
EMEA Expansion to Support BSX Stock Amid Fierce Competition
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
EMEA Expansion to Support BSX Stock Amid Fierce Competition
Positive
Zacks Investment Research
4 days ago
5 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility
Invest in stocks of EAT, BFST, AZEK, CLS and BSX to tap their high efficiency levels.
5 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility
Positive
Forbes
4 days ago
What's Behind The 130% Rise In BSX Stock?
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest stock increase may be due to the significant price appreciation ahead of the earnings announcement.
What's Behind The 130% Rise In BSX Stock?
Neutral
Zacks Investment Research
5 days ago
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog.
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Positive
Zacks Investment Research
6 days ago
Best Momentum Stocks to Buy for February 10th
BSX, ENVA and CFR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 10, 2025.
Best Momentum Stocks to Buy for February 10th
Positive
Zacks Investment Research
6 days ago
5 Momentum Stocks to Buy for February Amid Volatility
These five stocks have strong momentum for February. These are: APH, BSX, NLY, PNFP, FHN.
5 Momentum Stocks to Buy for February Amid Volatility
Positive
Zacks Investment Research
6 days ago
New Strong Buy Stocks for February 10th
PFIS, BSX, ENVA, NFG and NLY have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2025.
New Strong Buy Stocks for February 10th
Positive
Zacks Investment Research
1 week ago
Boston Scientific (BSX) is a Great Momentum Stock: Should You Buy?
Does Boston Scientific (BSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Boston Scientific (BSX) is a Great Momentum Stock: Should You Buy?
Positive
Zacks Investment Research
1 week ago
Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year?
Here is how Boston Scientific (BSX) and Alphatec (ATEC) have performed compared to their sector so far this year.
Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year?
Positive
Zacks Investment Research
1 week ago
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Charts implemented using Lightweight Charts™